
SAGE Therapeutics (SAGE) Earnings Dates & Reports
SAGE Therapeutics (SAGE) Most Recent Earnings
Report DateApr 29, 2025
Period EndingQ1 2025
Est. EPS-$1.01
Actual EPS-$1.01
EarningsMeet
SAGE Therapeutics (SAGE) Earnings
View the latest SAGE Therapeutics (SAGE) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in SAGE Therapeutics (SAGE)
Order type
Buy in
Order amount
Est. shares
0 shares
SAGE Therapeutics (SAGE) Earnings per Share (EPS) History
Signup for full accessBrowse free
SAGE Therapeutics (SAGE) Latest Earnings
The value each SAGE share was expected to gain vs. the value each share gained.
SAGE Therapeutics (SAGE) reported its most recent earnings on Apr 29, 2025 for Q1 2025, posting earnings per share (EPS) of -$1.01. This exceeded analysts' expectations of -$1.01 by 0.00%, marking a Meet.
For comparison, SAGE Therapeutics reported EPS of -$1.80 in the same quarter last year.
The company is expected to announce its next earnings report on 07/30/2025, with analysts projecting an EPS of -$0.94.
SAGE Therapeutics (SAGE) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Jul 30, 2025 | -$0.94 | Next earnings call Jul. 30, 2025 | ||
Q1 2025Apr 29, 2025 | -$1.01 | -$1.01 | 0.00% | |
Q4 2024Feb 11, 2025 | -$1.36 | -$1.56 | +14.71% | |
Q3 2024Oct 29, 2024 | -$1.53 | -$1.53 | 0.00% | |
Q2 2024Jul 31, 2024 | -$1.66 | -$1.70 | +2.41% | |
SAGE Therapeutics (SAGE) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the SAGE Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Apr 29, 2025 | — | — | — |
Feb 11, 2025 | — | — | — |
Oct 29, 2024 | — | — | — |
Jul 31, 2024 | — | — | — |
SAGE Therapeutics (SAGE) Earnings FAQs
SAGE Therapeutics (SAGE) last reported earnings on Apr 29, 2025 for Q1 2025, posting an EPS of -$1.01, which Meet the estimate of -$1.01 by 0.00%.
For Q1 2025, SAGE Therapeutics (SAGE) reported an EPS of -$1.01, missing analysts' estimate of -$1.01 by 0.00%.
For Q1 2025, SAGE Therapeutics (SAGE) Meet expectations with an actual EPS of -$1.01 vs. an estimated EPS of -$1.01.
Following the last earnings report on Apr 29, 2025, SAGE Therapeutics (SAGE)'s stock price moved — from — to —.
The next SAGE Therapeutics (SAGE) earnings call is scheduled for Jul. 30, 2025, where executives will discuss financial results and outlook.